Form 8-K - Current report:
SEC Accession No. 0001213900-24-061853
Filing Date
2024-07-16
Accepted
2024-07-16 17:28:43
Documents
14
Period of Report
2024-07-16
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0209525-8k_60degrees.htm   iXBRL 8-K 48136
  Complete submission text file 0001213900-24-061853.txt   268282

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE sxtp-20240716.xsd EX-101.SCH 3797
3 XBRL DEFINITION FILE sxtp-20240716_def.xml EX-101.DEF 26644
4 XBRL LABEL FILE sxtp-20240716_lab.xml EX-101.LAB 36712
5 XBRL PRESENTATION FILE sxtp-20240716_pre.xml EX-101.PRE 25268
17 EXTRACTED XBRL INSTANCE DOCUMENT ea0209525-8k_60degrees_htm.xml XML 5744
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

EIN.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 241120460
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)